Anne Hubbard, MBA, director of health policy for ASTRO, explains the details and purpose of the proposed Radiation Oncology Alternative Payment Model (RO Model) at the ASTRO 2019 meeting.
In July 2019, the Center for Medicare and Medicaid Innovation (CMMI) issued a proposed rule establishing the RO Model. It requires participation from about 40 percent of radiation oncology practices in a model that dramatically changes the way Medicare pays for radiation therapy services. The RO Model is designed to test whether prospective episode-based payments to physician group practices (PGPs), hospital outpatient departments (HOPDs) and freestanding radiation therapy centers for episodes of care would reduce Medicare expenditures while preserving or enhancing the quality of care for Medicare beneficiaries. CMMI proposes launching the model as early as Jan. 1, 2020.